Clinical Trials Directory

Trials / Completed

CompletedNCT02422602

Better Adherence With New Oral Anticoagulant in Atrial Fibrillation : Effectiveness of a Personalized Education Program

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
196 (actual)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is multicentric, single-blind, and interventional with a randomization into two parallel arm, between a standard of care information and an additional information of the patient, with a 12 month follow up. The aim of this study is to evaluate the effectiveness of a personalized information program versus information provided from standard of care in patients taking Xarelto for Stroke Prevention in Atrial Fibrillation.

Conditions

Interventions

TypeNameDescription
DRUGXareltoTaking conventional charge
OTHERExperimental: Personalized information intervention

Timeline

Start date
2013-11-26
Primary completion
2015-05-06
Completion
2016-05-06
First posted
2015-04-21
Last updated
2021-07-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02422602. Inclusion in this directory is not an endorsement.

Better Adherence With New Oral Anticoagulant in Atrial Fibrillation : Effectiveness of a Personalized Education Program (NCT02422602) · Clinical Trials Directory